chr19-45485716-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_005619.5(RTN2):c.1630G>A(p.Ala544Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00041 in 1,613,908 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005619.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTN2 | NM_005619.5 | c.1630G>A | p.Ala544Thr | missense_variant | Exon 11 of 11 | ENST00000245923.9 | NP_005610.1 | |
RTN2 | NM_206900.3 | c.1411G>A | p.Ala471Thr | missense_variant | Exon 10 of 10 | NP_996783.1 | ||
RTN2 | NM_206901.3 | c.610G>A | p.Ala204Thr | missense_variant | Exon 7 of 7 | NP_996784.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152164Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000160 AC: 40AN: 249938Hom.: 0 AF XY: 0.000229 AC XY: 31AN XY: 135230
GnomAD4 exome AF: 0.000436 AC: 637AN: 1461626Hom.: 2 Cov.: 31 AF XY: 0.000450 AC XY: 327AN XY: 727136
GnomAD4 genome AF: 0.000158 AC: 24AN: 152282Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74446
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 12 Uncertain:1Benign:1
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Spastic paraplegia Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 544 of the RTN2 protein (p.Ala544Thr). This variant is present in population databases (rs201387324, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with RTN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 653220). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1630G>A (p.A544T) alteration is located in exon 11 (coding exon 11) of the RTN2 gene. This alteration results from a G to A substitution at nucleotide position 1630, causing the alanine (A) at amino acid position 544 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at